Menu Search
Equities

Neogen Corp

NEOG:NSQ

Neogen Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)15.34
  • Today's Change-1.06 / -6.46%
  • Shares traded2.74m
  • 1 Year change+1.59%
  • Beta1.2481
Data delayed at least 15 minutes, as of Nov 12 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Neogen Corp grew revenues 12.37% from 822.45m to 924.22m while net income improved from a loss of 22.87m to a smaller loss of 9.42m.
Gross margin49.56%
Net profit margin-2.58%
Operating margin4.58%
Return on assets-0.52%
Return on equity-0.75%
Return on investment-0.53%
More ▼

Cash flow in USDView more

In 2024, Neogen Corp did not generate a significant amount of cash. However, the company earned 35.26m from its operations for a Cash Flow Margin of 3.82%. In addition the company generated 1.92m cash from financing while 29.31m was spent on investing.
Cash flow per share0.4352
Price/Cash flow per share37.71
Book value per share14.47
Tangible book value per share-2.27
More ▼

Balance sheet in USDView more

Neogen Corp has a Debt to Total Capital ratio of 22.15%, a lower figure than the previous year's 28.17%.
Current ratio4.41
Quick ratio2.79
Total debt/total equity0.2844
Total debt/total capital0.2215
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items increased 64.06%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		11.73
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.